Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jun;315(3):e242416.
doi: 10.1148/radiol.242416.

A Data-Centric Approach to Deep Learning for Brain Metastasis Analysis at MRI

Affiliations
Multicenter Study

A Data-Centric Approach to Deep Learning for Brain Metastasis Analysis at MRI

Laurens Topff et al. Radiology. 2025 Jun.

Abstract

Background With the increasing incidence of brain metastases (BMs), artificial intelligence models have shown promise in assisting with the detection and volumetric analysis of lesions at MRI. However, current models are limited in identifying small lesions and lack generalizability. Purpose To develop a generalizable deep learning system for detecting, segmenting, and longitudinally tracking BMs of any size at MRI. Materials and Methods In this retrospective study, a data-centric approach to deep learning model development was used. A multicenter dataset was collected, comprising pre- and/or posttreatment MRI scans from patients with BMs and MRI scans from patients with cancer without BMs (December 2015 to August 2023). Iterative data annotation by radiologists with systematic quality control increased the consistency of reference segmentations. A modified nnU-Net framework, with robust data preprocessing and augmentation, was used. Lesion-wise detection metrics and segmentation performance, Dice similarity coefficient, and normalized surface distance were evaluated. Results In total, 1985 scans from 1623 patients (mean age, 62.0 years ± 12.2 [SD]; 743 female patients, 157 patients of unknown sex), with 5552 BMs, were included. BMs were present in 64.8% of the scans (1286 of 1985), 36.0% (463 of 1286) of which were posttreatment scans. The model was trained on 1451 scans acquired on 30 different scanners. In internal testing (n = 223), sensitivity was 98.0% (95% CI: 96.3, 99.0; 449 of 458 lesions). In external testing (n = 311), sensitivity was 97.4% (95% CI: 96.2, 98.2; 935 of 960; P = .58), with a mean of 0.6 false positives per patient. The sensitivity remained high for all lesion sizes, including those less than 3 mm in diameter (93.3% [95% CI: 89.1, 96.0]; 196 of 210). Median Dice similarity coefficient was 0.89 and 0.90 for the internal and external test datasets, respectively (P = .13). Median normalized surface distance was 0.99 for both datasets. Conclusion The deep learning system demonstrated high performance and generalizability in detecting and segmenting BMs of all sizes on pre- and posttreatment MRI scans. © RSNA, 2025 Supplemental material is available for this article.

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: L.T. Valorization of the software developed in this study is being considered, for which institution may receive future royalties. L.P. No relevant relationships. N.J. No relevant relationships. S.L. No relevant relationships. J.B. Employee of Robovision. P.A. Support for the present manuscript from Robovision. M.P. No relevant relationships. P.M.F.M. No relevant relationships. O.G. Grants to institution from the National Cancer Institute, AstraZeneca, Food and Drug Administration, Saudi Company for Artificial Intelligence, Owkin, Onc. AI, University of California, Berkeley, and Roche Molecular Systems; honorarium for lecture from Princess Margaret Cancer Center, University of Toronto; support for attending meetings and/or travel from AZ Delta, Indonesia Ministry of Health, and Global AI Summit; and patent S21-177, provisional patent S22-425, and provisional patent S24-079. M.S. Consulting fees paid to institution from Bracco and board member of the Dutch Society of Radiology (unpaid) and European Society of Radiology (unpaid). S.D. No relevant relationships. E. Verhaak No relevant relationships. P.E.J.H. No relevant relationships. E.M.d.L. No relevant relationships. R.S. No relevant relationships. P.D.D. No relevant relationships. A.N. No relevant relationships. E. Visser No relevant relationships. D.C.F. No relevant relationships. L.M.M.B. No relevant relationships. D.B. No relevant relationships. J.J.V. Grants or contracts to institution from Qure.ai, Enlitic, Promedius, AstraZeneca, and Philips; payment or honoraria to institution for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Roche; support for attending meetings or travel from Qure.ai; participation on a data and safety monitoring board or advisory board for Quibim, Contextflow, and Noaber Foundation; chair of the scientific committee of the European Society of Medical Imaging Informatics (unpaid); chair of the European Society of Radiology Value-based Radiology Subcommittee (unpaid); junior editor for European Journal of Radiology (unpaid); member of the RSNA Common Data Elements Steering Committee (unpaid); and stock or stock options from Quibim and Contextflow. E.R.R. No relevant relationships. K.B.W.G.L. Public private partnership grant (TKI-LSH) from Health-Holland with ScreenPoint Medical, and chairman of the Young Club of the European Society of Medical Imaging Informatics. R.G.H.B.T. No relevant relationships.

References

    1. Lamba N , Wen PY , Aizer AA . Epidemiology of brain metastases and leptomeningeal disease . Neuro Oncol 2021. ; 23 ( 9 ): 1447 – 1456 . - PMC - PubMed
    1. Aizer AA , Lamba N , Ahluwalia MS , et al . Brain metastases: a Society for Neuro-Oncology (SNO) consensus review on current management and future directions . Neuro Oncol 2022. ; 24 ( 10 ): 1613 – 1646 . - PMC - PubMed
    1. Le Rhun E , Guckenberger M , Smits M , et al. ; EANO Executive Board and ESMO Guidelines Committee . EANO–ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours . Ann Oncol 2021. ; 32 ( 11 ): 1332 – 1347 . - PubMed
    1. Derks SHAE , van der Veldt AAM , Smits M . Brain metastases: the role of clinical imaging . Br J Radiol 2022. ; 95 ( 1130 ): 20210944 . - PMC - PubMed
    1. Qu J , Zhang W , Shu X , et al . Construction and evaluation of a gated high-resolution neural network for automatic brain metastasis detection and segmentation . Eur Radiol 2023. ; 33 ( 10 ): 6648 – 6658 . - PubMed

Publication types

LinkOut - more resources